menu
    • menu

    Company profile for Zentalis Pharmaceuticals

    NEW Drugs in Dev: 4
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    AbbVie Contract Manufacturing partners globally to develop, scale, and manufacture pharmaceutical products successfully.

    Virtual Booth

    Contact Supplier

    Topscience Biotech is a one-stop supplier of sodium hyaluronate//drug manufacturing license, CEP, GMP, DMF, and Form 41 certifications.

    Virtual Booth

    Contact Supplier

    Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    At Zentalis, we are developing clinically differentiated therapeutics targeting fundamental cancer pathways that have the potential to address major unmet medical needs for patients with cancer. We have successfully advanced three compounds into the clinic in the Company’s first five years, all internally developed using the deep chemistry capabilities of our integrated discovery engine.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Zentalis PharmaceuticalsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    530 Seventh Avenue Suite 2201 New York, NY 10018
    Telephone
    Telephone
    1-212-433-3791
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://zentalis.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/zentalis-pharmaceuticals/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Zentalis Pharma Reveals Inducement Grants Per Nasdaq LR
    Zentalis Pharma Reveals Inducement Grants Per Nasdaq LR

    01 Jun 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/06/01/3304753/0/en/zentalis-pharmaceuticals-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4.html

    GLOBENEWSWIRE
    01 Jun 2026
    Share Share
    Zentalis Appoints Shannon Campbell to Board, Names SVP Sales
    Zentalis Appoints Shannon Campbell to Board, Names SVP Sales

    27 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/27/3302381/0/en/zentalis-strengthens-commercial-leadership-with-appointments-of-shannon-campbell-to-board-of-directors-and-sarah-kelly-as-svp-of-commercial-strategy.html

    GLOBENEWSWIRE
    27 May 2026
    Share Share
    Zentalis Presents Azenosertib + Paclitaxel MUIR Data at ASCO 2026
    Zentalis Presents Azenosertib + Paclitaxel MUIR Data at ASCO 2026

    21 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/21/3299814/0/en/zentalis-pharmaceuticals-to-present-phase-1b-muir-trial-data-showing-encouraging-clinical-activity-and-manageable-safety-profile-of-azenosertib-plus-paclitaxel-in-platinum-resistan.html

    GLOBENEWSWIRE
    21 May 2026
    Share Share
    Zentalis Pharma to Attend Upcoming Investor Conferences
    Zentalis Pharma to Attend Upcoming Investor Conferences

    13 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/13/3294413/0/en/zentalis-pharmaceuticals-to-participate-in-upcoming-investor-conferences.html

    GLOBENEWSWIRE
    13 May 2026
    Share Share
    Zentalis Pharma Reveals Q1 2026 Financials And Clinical Advances
    Zentalis Pharma Reveals Q1 2026 Financials And Clinical Advances

    12 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/12/3293397/0/en/zentalis-pharmaceuticals-reports-first-quarter-2026-financial-results-and-clinical-progress.html

    GLOBENEWSWIRE
    12 May 2026
    Share Share
    Zentalis Doses First Patient in Phase 3 ASPENOVA Trial
    Zentalis Doses First Patient in Phase 3 ASPENOVA Trial

    05 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/05/3287628/0/en/zentalis-pharmaceuticals-announces-first-patient-dosed-in-aspenova-phase-3-trial-of-azenosertib-in-patients-with-cyclin-e1-positive-platinum-resistant-ovarian-cancer.html

    GLOBENEWSWIRE
    05 May 2026
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search